Mast cell density and the context of clinicopathological parameters and expression of p185, estrogen receptor, and proliferating cell nuclear antigen in gastric carcinoma

Table 1 Correlation between MCD and Clinicopathologic find-ing of gastric carcinoma (n = 100)

Variable	MCD > 21/0.03 mm2	MCD ≤ 21/0.03 mm2	P Value
Age (yrs)
< 60	16	25	< 0.05
≥ 60	36	23
Degree of differentiation
Well	18	14	> 0.05
Moderately	23	21
Poorly	11	13
Largest dimension of tumor ( in mm)
≤ 30	30	36	> 0.05
> 30	22	12
Depth of penetration
Involved serosa	21	34	< 0.01
Not involved serosa	31	14

Table 2 Correlation between MCD and cancerous metastases in regional lymph nodes (n = 41)

Variable	n	MCD (mean ± SD, /mm2)
1-6 ILN	21	12 ± 3.11
7-15 ILN	14	6 ± 2.06
> 15 ILN	6	5 ± 1.33

ILN: involved lymph nodes

Table 3 Correlation between MCD and the positive expression rate of p185, ER, and PCNA in the gastric carcinoma tissues

MCD	n	Positive expression rate (%)
		p185	ER	PCNA
> 21/0.03 mm2	52	22 (42.31)	11 (21.15)	12 (23.08)
≤ 21/0.03 mm2	48	31 (59.62)	28 (53.84)	27 (51.92)
P Value		< 0.01	< 0.001	< 0.01